Cell death classification has been based on morphological characteristics for decades. Modern advances in molecular technology enabled us to explore cell death pathways on a level of unprecedented detail. While necrosis has been considered a negative unpreventable form of cell death, recent findings demonstrate that a subtype of necrosis, namely necroptosis, is a regulated programmed process. Hence, therapeutic intervention to inhibit necroptosis-mediated loss of cells in a disease process is possible. This review highlights recent advances in programmed necrosis (necroptosis) and its potential relationship to human disease.
Harraz, M. (2014). Programmed Necrosis-mediated Cell Death and Disease: Recent Advances. Suez Canal University Medical Journal, 17(1), 1-9. doi: 10.21608/scumj.2014.45311
MLA
Maged M Harraz. "Programmed Necrosis-mediated Cell Death and Disease: Recent Advances", Suez Canal University Medical Journal, 17, 1, 2014, 1-9. doi: 10.21608/scumj.2014.45311
HARVARD
Harraz, M. (2014). 'Programmed Necrosis-mediated Cell Death and Disease: Recent Advances', Suez Canal University Medical Journal, 17(1), pp. 1-9. doi: 10.21608/scumj.2014.45311
VANCOUVER
Harraz, M. Programmed Necrosis-mediated Cell Death and Disease: Recent Advances. Suez Canal University Medical Journal, 2014; 17(1): 1-9. doi: 10.21608/scumj.2014.45311
)
View on SCiNiTO